Egalet (EGLT) Misses Q1 EPS by 73c, Miss on Revenues

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AAPL
2. PLTR
3. VRTX
4. DOX
5. CRWD
6. CHKP
7. ON
8. HNGE
9. INSP
10. CVI

Go back to Egalet (EGLT) Misses Q1 EPS by 73c, Miss on Revenues

Egalet (EGLT) Announces Coverage of SPRIX Nasal Spray and ARYMO ER by National Pharmacy Benefit Manager

May 7, 2018 6:09 AM EDT

Egalet Corporation (NASDAQ: EGLT) today announced that a national pharmacy benefit manager (PBM) covering 3.5 million member lives has placed SPRIX (ketorolac tromethamine) Nasal Spray in a tier 2 preferred position and ARYMO ER (morphine sulfate) extended-release (ER) tablets for oral use only CII in a tier 3 unrestricted position effective immediately.

"The coverage of SPRIX and AYRMO ER by this national PBM is an important development given our strategy to expand payer coverage of our products," said Patrick Shea, chief commercial officer of Egalet. "With this national PBM and the regional plans recently covering... More